Jeevan Scientific Technology last traded at ₹85.50 (2026-10-13). Over the past month the stock moved +5.0%, three months the stock moved +1.9%, year the stock moved +121.6%. Its closing range over 52 weeks is ₹59.88 – ₹87.90, with the latest close 2.7% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1999, Jeevan Scientific Technology Ltd is an Independent Clinical Contract Research Organization which offers technology-driven clinical research solutions[1]
Services Offered:[1][2] a) Clinical Trial Services: Patient PK trials, Pharmacodynamic endpoint studies, Early & late phase clinical trials, Post-marketing surveillance studies, Investigator initiated and real-world evidence studies, Clinical Trials Support for Complex Generics & Biosimilars b) Bioavailability & Bioequivalence Services: MD/MV and subject sample analysis, Statistical Analysis and Data Management, SAS and Win Nonlin, CDISC, Healthy and Patient based BA/BE studies Food effect, Age Effect, Gender effect studies, Studies in both male and female subjects (Pre and Postmenopausal women), PK/PD endpoint studies, SAD and MAD studies, etc. c) Pharmacovigilance Services: Data migration, Database management, Literature search services, regulatory inspection /audit support, etc.
In the latest quarter (Jun 2026), Jeevan Scientific Technology reported sales of ₹18.28 crore (+107.7%) and net profit of ₹0.87 crore, compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 18.28 | 2.95 | 16.14 | 0.87 | 0.27 |
| Mar 2026 | 21.29 | 4.29 | 20.15 | 1.84 | 0.81 |
| Dec 2025 | 19.07 | 5.23 | 27.43 | 2.40 | 0.90 |
| Sep 2025 | 12.38 | 2.07 | 16.72 | 0.01 | -0.06 |
| Jun 2025 | 8.80 | -1.78 | -20.23 | -3.22 | -1.96 |
| Mar 2025 | 10.06 | -0.38 | -3.78 | -1.26 | -0.82 |
| Dec 2024 | 12.51 | 2.07 | 16.55 | 0.05 | 0.07 |
| Sep 2024 | 11.40 | 2.50 | 21.93 | 0.25 | 0.16 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +41.4% | +23.5% | -9.1% | -31.7% | +8.6% | +52.4% | +111.6% | +107.7% |
| Operating profit growth | +316.7% | +105.0% | -138.8% | -155.1% | -17.2% | +152.7% | – | – |
| Net profit growth | – | – | – | -412.6% | -96.0% | +4700.0% | – | – |
| EPS growth | – | – | – | -380.0% | -137.5% | +1185.7% | – | – |
| OPM % | 21.9% | 16.6% | -3.8% | -20.2% | 16.7% | 27.4% | 20.2% | 16.1% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Jeevan Scientific Technology reported sales of ₹61.54 crore (+31.4%) and net profit of ₹1.03 crore (+1960.0%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 61.54 | 9.80 | 15.92 | 1.03 | 0.58 |
| Mar 2025 | 46.84 | 7.41 | 15.82 | 0.05 | 0.08 |
| Mar 2024 | 39.65 | 4.64 | 11.70 | -1.33 | -0.84 |
| Mar 2023 | 36.18 | 1.36 | 3.76 | -3.07 | -1.97 |
| Mar 2022 | 67.79 | 16.77 | 24.74 | 11.94 | 7.80 |
| Mar 2021 | 46.90 | 17.49 | 37.29 | 11.74 | 7.67 |
| Mar 2020 | 23.94 | -6.08 | -25.40 | -8.59 | -5.61 |
| Mar 2019 | 26.13 | 5.86 | 22.43 | 1.11 | 0.73 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +28.2% | -8.4% | +95.9% | +44.5% | -46.6% | +9.6% | +18.1% | +31.4% |
| Operating profit growth | +70.8% | -203.8% | – | -4.1% | -91.9% | +241.2% | +59.7% | +32.3% |
| Net profit growth | +909.1% | -873.9% | – | +1.7% | -125.7% | – | – | +1960.0% |
| EPS growth | +630.0% | -868.5% | – | +1.7% | -125.3% | – | – | +625.0% |
| OPM % | 22.4% | -25.4% | 37.3% | 24.7% | 3.8% | 11.7% | 15.8% | 15.9% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Jeevan Scientific Technology.
Get Free AI Stock Analysis FREE →USFDA inspects Jeevan Scientific Technology’s bioanalytical facility at Hyderabad
Jeevan Scientific Technology shares were last quoted at ₹85.50 (+2.3% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Jeevan Scientific Technology has a price-to-earnings (P/E) ratio of 45.58 and a price-to-book (P/B) ratio of 2.18. The industry P/E is 101.02.
The 52-week high of Jeevan Scientific Technology is ₹93.90 and the 52-week low is ₹32.85.
The market capitalisation of Jeevan Scientific Technology is about ₹158.89 crore.
In the latest quarter (Jun 2026), Jeevan Scientific Technology reported sales of ₹18.28 crore (+107.7%) and net profit of ₹0.87 crore, compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Jeevan Scientific Technology has a 3-year ROE of 0.00%, 3-year profit growth of 33.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 30.25% of Jeevan Scientific Technology.
Jeevan Scientific Technology belongs to the IT Services & Consulting sector.